Inhibitory effects of ginseng total saponin on nicotine-induced hyperactivity, reverse tolerance and dopamine

H S Kim1, K S Kim

  • 1College of Pharmacy, Chungbuk National University, Cheongju, South Korea. hskim@trut.chungbuk.ac.kr

Behavioural Brain Research
|September 4, 1999
PubMed

Insights

Ginseng total saponin (GTS) mitigates nicotine-induced hyperactivity and reverse tolerance in mice. GTS also inhibits the development of dopamine receptor supersensitivity, suggesting a protective role against nicotine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Nicotine administration can induce hyperactivity and reverse tolerance, characterized by an increased ambulatory response.
  • Repeated nicotine exposure leads to postsynaptic dopamine receptor supersensitivity, evidenced by enhanced responses to dopamine agonists like apomorphine.

Purpose of the Study:

  • To investigate the effects of ginseng total saponin (GTS) on nicotine-induced hyperactivity, reverse tolerance, and dopamine receptor supersensitivity in mice.
  • To explore the potential role of dopaminergic pathways and receptor sensitivity in nicotine's behavioral effects and GTS's modulatory actions.

Main Methods:

  • Mice were administered nicotine to induce hyperactivity and reverse tolerance.
  • Ginseng total saponin (GTS) was administered before and during nicotine treatment.
  • Ambulatory activity was measured to assess responses to nicotine and apomorphine (a dopamine receptor agonist).

Main Results:

  • Ginseng total saponin (GTS) inhibited nicotine-induced hyperactivity.
  • GTS prevented the development of reverse tolerance to nicotine's ambulation-accelerating effects.
  • GTS also inhibited the development of postsynaptic dopamine receptor supersensitivity in nicotine-treated mice.

Conclusions:

  • Ginseng total saponin (GTS) effectively inhibits nicotine-induced hyperactivity and reverse tolerance.
  • The inhibitory effects of GTS may be linked to the modulation of dopaminergic activation and dopamine receptor sensitivity.
  • GTS demonstrates potential in mitigating adverse behavioral and neurochemical changes associated with nicotine exposure.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.9K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
878